PDA Education Adds Equipment to Training and Research Institute, Releases Information Video

News provided by

Apr 02, 2015, 06:14 ET

BETHESDA, Md., April 2, 2015 /PRNewswire-USNewswire/ -- PDA Education, part of the Parenteral Drug Association (PDA), announces the installation of new equipment in the Training and Research Institute (TRI) in Bethesda.

Of particular note is the installation of a Bioquell isolator at TRI that will be incorporated into its hands-on educational courses including the industry-leading Aseptic Processing Training Program.

PDA Education also has released a new video on the value of PDA Education's distinctive industry training programs, both at TRI and lecture courses hosted at off-site locations.

About PDA – Connecting People, Science and Regulation®

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its nearly 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.

About PDA Education

PDA offers both lecture and hands-on laboratory instruction at its Training and Research Institute (TRI) facility, located at PDA's Global Headquarters in Bethesda, Maryland.

The only stand-alone facility of its kind, PDA's TRI features an aseptic processing suite, including a fill room, gowning room, component prep lab, and a clean staging area. The facility also houses microbiology, biotechnology, and Clean-In-Place labs, along with traditional classrooms, all of which are used during laboratory training courses.

Media Inquiries: Walt Morris, 301-656-5900, x. 148; [email protected]

Video - http://origin-qps.onstreammedia.com/origin/multivu_archive/PRNA/ENR/1291214-1-1-pda-education.mp4

Logo - http://photos.prnewswire.com/prnh/20130226/DC66667LOGO

SOURCE Parenteral Drug Association